September 2022 Price Concessions 1st Update
THIS CONTENT HAS NOW EXPIRED
The Department of Health and Social Care (DHSC) has today (20/09/2022) granted the following initial list of price concessions:
|Alendronic acid 70mg tablets
|Amisulpride 100mg tablets
|Amisulpride 200mg tablets
|Amisulpride 50mg tablets
|Amorolfine 5% medicated nail lacquer
|Amoxicillin 250mg/5ml oral suspension
|Amoxicillin 250mg/5ml oral suspension sugar free
|Bimatoprost 100micrograms/ml eye drops
|Bisacodyl 5mg gastro-resistant tablets
|Brimonidine 0.2% eye drops
|Chlorpromazine 100mg tablets
|Chlorpromazine 25mg tablets
|Chlorpromazine 50mg tablets
|Clarithromycin 250mg/5ml oral suspension
|Dipyridamole 100mg tablets
|Duloxetine 30mg gastro-resistant capsules
|Duloxetine 60mg gastro-resistant capsules
|Escitalopram 10mg tablets
|Escitalopram 5mg tablets
|Temazepam 10mg tablets
PSNC is seeking improvements to the current price concessions system following significant concerns raised by pharmacy contractors about the unsustainable level of prices, imposed by DHSC in the past few months, for certain medicines. To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of PSNC’s recent webinar here.
No additional endorsements are required for price concessions. A price concession only applies for the month in which it is granted.
PSNC is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated September 2022 Drug Tariff price. Please note that PSNC cannot provide details of any generic products awaiting price concession approval from DHSC.
If you have problems obtaining a Part VIII product at the stated Drug Tariff price, please report the issue using the online feedback form on the PSNC website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. PSNC will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Contractors will be alerted to further updates to the price concession list through our website and via our e-news email. If you wish to subscribe to our email list, you can receive an email as soon as any announcements are made.